Case Number: 1:13-cv-03188-SHS (Dkt. 14)
The court entered a consent judgment in Purdue’s suit over U.S. Patent No. 8,337,888 (entitled “Pharmaceutical formulation containing gelling agent”), limited to “Oxycodone Products.” The parties agreed that the patent is valid, enforceable and infringed by Impax’s ANDA products, and that according to the parties’ Settlement Agreement, Impax will not market these products until an undisclosed “Terminal Date.”
The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.